The motion: Prevention of prostate cancer with a 5α-reductase inhibitor is feasible

Claus Roehrborn, Yair Lotan, Andrea Tubaro, Cosimo De Nunzio, C. G. Roehrborn, Y. Lotan, A. Tubaro, C. De Nunzio

Research output: Contribution to journalComment/debatepeer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'The motion: Prevention of prostate cancer with a 5α-reductase inhibitor is feasible'. Together they form a unique fingerprint.